AG
RETA

Artal Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Artal Group’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-50,000
Closed -$10.2M – 113
2019
Q4 		$10.2M Buy
+50,000
New +$10.2M 0.39% 42